Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
Authors/Creators
- 1. Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic
- 2. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
- 3. Center for Primary Health Care Research, Lund University, 20502 Malmö, Sweden; kristina.sundquist@med.lu.se (K.S.); jan.sundquist@med.lu.se (J.S.); a.foersti@dkfz.de (A.F.); xinjun.li@med.lu.se (X.L.)
- 4. Department of Family Medicine and Community Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029-6574, USA
- 5. Center for Community-Based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Izumo-shi 693-8501, Japan
- 6. Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany
- 7. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
- 8. Department of Surgery, University Hospital, School of Medicine in Pilsen, 323 00 Pilsen, Czech Republic
- 9. Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland
- 10. Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland
Description
Liver cancer is often used as a general term for cancers of the liver (hepatocellular carcinoma, HCC), the gallbladder, and the bile ducts. The well-known risk factors are alcohol and viral hepatitis, but these are risk factors of mainly HCC. For gallbladder cancer, gallstones are important risk factors, and for bile ducts, infections in the ducts are important. For all these cancers, autoimmune diseases and diabetes increase risk. This study shows that these risk factors, in combination, explain 50% or more of the causes of these cancers. The novelty of the present study was the use of national Swedish hospital records for potential risk factors (comorbidities) of hepatobiliary cancers and the estimation of subsequent risks of hepatobiliary cancers in these patients. The underlying mechanism for these cancers is a chronic infection which should be considered a marker of disease progression and a possible target for intervention.
Files
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:764ce263020de7b8f51cf8b8a87196a8
|
1.1 MB | Preview Download |
Additional details
Dates
- Available
-
2023-06-07